Zimmer Biomet Statistics
Share Statistics
Zimmer Biomet has 199.07M shares outstanding. The number of shares has increased by -4.65% in one year.
| Shares Outstanding | 199.07M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -2.25% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 198.79M |
| Failed to Deliver (FTD) Shares | 66 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 6.77M, so 3.4% of the outstanding shares have been sold short.
| Short Interest | 6.77M |
| Short % of Shares Out | 3.4% |
| Short % of Float | 3.4% |
| Short Ratio (days to cover) | 4.69 |
Valuation Ratios
The PE ratio is 24.8 and the forward PE ratio is 12.74. Zimmer Biomet 's PEG ratio is 0.17.
| PE Ratio | 24.8 |
| Forward PE | 12.74 |
| PS Ratio | 3.43 |
| Forward PS | 2.5 |
| PB Ratio | 2.04 |
| P/FCF Ratio | 21.09 |
| PEG Ratio | 0.17 |
Enterprise Valuation
Zimmer Biomet Inc. has an Enterprise Value (EV) of 31.10B.
| EV / Earnings | 30.37 |
| EV / Sales | 4.21 |
| EV / EBITDA | 14.05 |
| EV / EBIT | 24.34 |
| EV / FCF | 25.83 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.61 |
| Quick Ratio | 0.78 |
| Debt / Equity | 0.46 |
| Total Debt / Capitalization | 31.61 |
| Cash Flow / Debt | 0.27 |
| Interest Coverage | 6.35 |
Financial Efficiency
Return on equity (ROE) is 0.08% and return on capital (ROIC) is 6.64%.
| Return on Equity (ROE) | 0.08% |
| Return on Assets (ROA) | 0.05% |
| Return on Capital (ROIC) | 6.64% |
| Revenue Per Employee | 410.79K |
| Profits Per Employee | 56.89K |
| Employee Count | 18.00K |
| Asset Turnover | 0.34 |
| Inventory Turnover | 0.87 |
Taxes
| Income Tax | 42.20M |
| Effective Tax Rate | 0.04 |
Stock Price Statistics
The stock price has increased by -14.67% in the last 52 weeks. The beta is 1.02, so Zimmer Biomet 's price volatility has been higher than the market average.
| Beta | 1.02 |
| 52-Week Price Change | -14.67% |
| 50-Day Moving Average | 107.98 |
| 200-Day Moving Average | 111.21 |
| Relative Strength Index (RSI) | 44.88 |
| Average Volume (20 Days) | 1.54M |
Income Statement
In the last 12 months, Zimmer Biomet had revenue of 7.39B and earned 1.02B in profits. Earnings per share was 4.91.
| Revenue | 7.39B |
| Gross Profit | 5.31B |
| Operating Income | 1.28B |
| Net Income | 1.02B |
| EBITDA | 2.21B |
| EBIT | 1.28B |
| Earnings Per Share (EPS) | 4.91 |
Balance Sheet
The company has 415.80M in cash and 6.00B in debt, giving a net cash position of -5.58B.
| Cash & Cash Equivalents | 415.80M |
| Total Debt | 6.00B |
| Net Cash | -5.58B |
| Retained Earnings | 10.38B |
| Total Assets | 21.72B |
| Working Capital | 1.29B |
Cash Flow
In the last 12 months, operating cash flow was 1.58B and capital expenditures -602.80M, giving a free cash flow of 1.20B.
| Operating Cash Flow | 1.58B |
| Capital Expenditures | -602.80M |
| Free Cash Flow | 1.20B |
| FCF Per Share | 5.77 |
Margins
Gross margin is 71.82%, with operating and profit margins of 17.28% and 13.85%.
| Gross Margin | 71.82% |
| Operating Margin | 17.28% |
| Pretax Margin | 14.43% |
| Profit Margin | 13.85% |
| EBITDA Margin | 29.95% |
| EBIT Margin | 17.28% |
| FCF Margin | 16.28% |
Dividends & Yields
ZBH pays an annual dividend of $0.48, which amounts to a dividend yield of 0.46%.
| Dividend Per Share | $0.48 |
| Dividend Yield | 0.46% |
| Dividend Growth (YoY) | 0% |
| Payout Ratio | 9.16% |
| Earnings Yield | 4.69% |
| FCF Yield | 5.78% |
Analyst Forecast
The average price target for ZBH is $119.5, which is 14.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $119.5 |
| Price Target Difference | 14.2% |
| Analyst Consensus | Hold |
| Analyst Count | 20 |
Stock Splits
The last stock split was on Mar 1, 2022. It was a forward split with a ratio of 103:100.
| Last Split Date | Mar 1, 2022 |
| Split Type | forward |
| Split Ratio | 103:100 |
Scores
| Altman Z-Score | 2.7 |
| Piotroski F-Score | 8 |